Larimar Therapeutics (LRMR) Research & Development: 2014-2019
Historic Research & Development for Larimar Therapeutics (LRMR) over the last 6 years, with Dec 2019 value amounting to $423,000.
- Larimar Therapeutics' Research & Development fell 96.31% to $423,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $23.9 million, marking a year-over-year decrease of 50.16%. This contributed to the annual value of $23.9 million for FY2019, which is 50.16% down from last year.
- Latest data reveals that Larimar Therapeutics reported Research & Development of $423,000 as of Q4 2019, which was down 91.96% from $5.3 million recorded in Q3 2019.
- Larimar Therapeutics' 5-year Research & Development high stood at $17.7 million for Q4 2015, and its period low was $423,000 during Q4 2019.
- In the last 3 years, Larimar Therapeutics' Research & Development had a median value of $10.1 million in 2017 and averaged $9.4 million.
- Per our database at Business Quant, Larimar Therapeutics' Research & Development skyrocketed by 211.91% in 2015 and then tumbled by 96.31% in 2019.
- Over the past 5 years, Larimar Therapeutics' Research & Development (Quarterly) stood at $17.7 million in 2015, then plummeted by 58.91% to $7.3 million in 2016, then spiked by 49.98% to $10.9 million in 2017, then climbed by 5.00% to $11.5 million in 2018, then crashed by 96.31% to $423,000 in 2019.
- Its Research & Development was $423,000 in Q4 2019, compared to $5.3 million in Q3 2019 and $8.6 million in Q2 2019.